(Q57129057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Clinical application of circulating tumor cells in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Leonie H A Broersen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Rob A E M Tollenaar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Wilma E Mesker

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

19 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

9-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13402-013-0160-6

1 March 2020

exact match

0 references

cites work

Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Expected clinical applications of circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Progress in circulating tumor cell capture and analysis: implications for cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

A new look at node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Association between lymph node evaluation for colon cancer and node positivity over the past 20 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Disseminated and circulating tumor cells: Role in effective cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Molecular signature detection of circulating tumor cells using a panel of selected genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Inertial migration of cancer cells in blood flow in microchannels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Challenges in the enumeration and phenotyping of CTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Circulating tumour cells in locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Role of circulating tumor cells and disseminated tumor cells in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Circulating tumor cells in solid cancer: tumor marker of clinical relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Cancer stem cells in breast: current opinion and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Stem cells in breast tumours: are they ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0160-6

Technology update for the sorting and identification of breast cancer stem cells

21 January 2018

1 reference

12 December 2020

Circulating tumor cells as markers for cancer risk assessment and treatment monitoring

1 reference

12 December 2020

Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients

1 reference

12 December 2020

Detection of tumor cells in bone marrow, peripheral blood and lymph nodes by automated imaging devices.

1 reference

12 December 2020

Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery

1 reference

12 December 2020

Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts

1 reference

12 December 2020

Determination of cut-offs for circulating tumor cell measurement in metastatic cancer

1 reference

12 December 2020

Methods for detection of circulating tumour cells and their clinical value in cancer patients.

1 reference

12 December 2020

Circulating tumor cells in breast cancer

1 reference

12 December 2020

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

1 reference

12 December 2020

10.1007/S13402-013-0160-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24249155%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference